Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)

NCT01253408 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Dronabinol
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]